免疫疗法
癌症免疫疗法
癌症
癌症治疗
临床试验
重症监护医学
生物
医学
生物信息学
内科学
作者
Priti S. Hegde,Daniel S. Chen
出处
期刊:Immunity
[Elsevier]
日期:2020-01-01
卷期号:52 (1): 17-35
被引量:1413
标识
DOI:10.1016/j.immuni.2019.12.011
摘要
Summary
Cancer immunotherapy is a validated and critically important approach for treating patients with cancer. Given the vast research and clinical investigation efforts dedicated to advancing both endogenous and synthetic immunotherapy approaches, there is a need to focus on crucial questions and define roadblocks to the basic understanding and clinical progress. Here, we define ten key challenges facing cancer immunotherapy, which range from lack of confidence in translating pre-clinical findings to identifying optimal combinations of immune-based therapies for any given patient. Addressing these challenges will require the combined efforts of basic researchers and clinicians, and the focusing of resources to accelerate understanding of the complex interactions between cancer and the immune system and the development of improved treatment options for patients with cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI